WD Rutherford LLC Has $3.93 Million Stake in The Cooper Companies, Inc. (NASDAQ:COO)

WD Rutherford LLC grew its position in The Cooper Companies, Inc. (NASDAQ:COO) by 324.7% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 38,756 shares of the medical device company’s stock after purchasing an additional 29,630 shares during the quarter. Cooper Companies comprises approximately 2.0% of WD Rutherford LLC’s investment portfolio, making the stock its 18th biggest position. WD Rutherford LLC’s holdings in Cooper Companies were worth $3,932,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in COO. Congress Asset Management Co. MA grew its position in Cooper Companies by 252.4% during the first quarter. Congress Asset Management Co. MA now owns 1,263,754 shares of the medical device company’s stock worth $128,220,000 after buying an additional 905,173 shares in the last quarter. Norges Bank acquired a new stake in Cooper Companies during the fourth quarter worth approximately $196,045,000. Victory Capital Management Inc. grew its position in Cooper Companies by 16.5% during the fourth quarter. Victory Capital Management Inc. now owns 995,245 shares of the medical device company’s stock worth $376,641,000 after buying an additional 140,700 shares in the last quarter. International Assets Investment Management LLC acquired a new stake in Cooper Companies during the fourth quarter worth approximately $44,397,000. Finally, Ameriprise Financial Inc. boosted its holdings in shares of Cooper Companies by 47.0% in the 3rd quarter. Ameriprise Financial Inc. now owns 354,909 shares of the medical device company’s stock valued at $112,865,000 after purchasing an additional 113,395 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Stock Down 0.4 %

Shares of COO traded down $0.32 during trading hours on Friday, hitting $87.30. The stock had a trading volume of 1,966,387 shares, compared to its average volume of 1,275,055. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.95 and a quick ratio of 1.14. The firm has a 50 day simple moving average of $92.73 and a 200-day simple moving average of $94.73. The firm has a market capitalization of $17.38 billion, a P/E ratio of 51.28, a price-to-earnings-growth ratio of 2.17 and a beta of 1.02. The Cooper Companies, Inc. has a 1-year low of $75.93 and a 1-year high of $104.07.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, May 30th. The medical device company reported $0.85 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.83 by $0.02. The business had revenue of $942.60 million during the quarter, compared to the consensus estimate of $948.07 million. Cooper Companies had a return on equity of 8.87% and a net margin of 9.11%. The company’s quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.77 EPS. Sell-side analysts predict that The Cooper Companies, Inc. will post 3.57 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on COO. Stifel Nicolaus reaffirmed a “buy” rating and issued a $110.00 target price (up previously from $105.00) on shares of Cooper Companies in a report on Friday, March 1st. Piper Sandler increased their price target on Cooper Companies from $110.00 to $115.00 and gave the company an “overweight” rating in a research note on Friday, March 1st. Robert W. Baird increased their price target on Cooper Companies from $116.00 to $118.00 and gave the company an “outperform” rating in a research note on Friday, May 31st. Redburn Atlantic upgraded Cooper Companies from a “neutral” rating to a “buy” rating and set a $125.00 price target for the company in a research note on Tuesday, March 19th. Finally, Citigroup increased their price target on Cooper Companies from $108.00 to $116.00 and gave the company a “buy” rating in a research note on Wednesday, April 3rd. Four research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $111.42.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.